相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
High Efficacy of a Listeria-Based Vaccine against Metastatic Breast Cancer Reveals a Dual Mode of Action
Sun Hee Kim et al.
CANCER RESEARCH (2009)
Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
Anu Wallecha et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors
Matthew M. Seavey et al.
CLINICAL CANCER RESEARCH (2009)
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
Paulo Cesar Maciag et al.
VACCINE (2009)
Development of a Listeria monocytogenes based vaccine against prostate cancer
Vafa Shahabi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Can we circumvent resistance to ErbB2-targeted agents by targeting novel pathways?
Mark Pegram
CLINICAL BREAST CANCER (2008)
Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating Foxp3+ regulatory T cells
Sylvain Ladoire et al.
CLINICAL CANCER RESEARCH (2008)
Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector
Hiroyoshi Nishikawa et al.
BLOOD (2008)
Listeriolysin O expressed in a bacterial vaccine suppresses CD4+ CD25high regulatory T cell function in vivo
Josianne Nitcheu-Tefit et al.
JOURNAL OF IMMUNOLOGY (2007)
Immunoediting sculpts tumor epitopes during immunotherapy
Reshma Singh et al.
CANCER RESEARCH (2007)
A truncated Bacillus subtilis dal gene with a 3′ ssrA gene tag regulates the growth and virulence of racemase-deficient Listeria monocytogenes
Zhongxia Li et al.
MICROBIOLOGY-SGM (2006)
Central nervous system tumor immunity generated by a recombinant Listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden
RM Prins et al.
NEUROSURGERY (2006)
Fusion to listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse
R Singh et al.
JOURNAL OF IMMUNOLOGY (2005)
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules:: implications for tumor immune escape
I Algarra et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other vectors and DNA vaccines
T Verch et al.
INFECTION AND IMMUNITY (2004)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts
C Peters et al.
VACCINE (2003)
HLA class I antigen loss, tumor immune escape and immune selection
M Campoli et al.
VACCINE (2002)
Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16
GR Gunn et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
